Results 261 to 270 of about 874,843 (291)
A Novel Autoimmune Presentation of Wiskott-Aldrich Syndrome: Type 1 Diabetes. [PDF]
Rayan MN +3 more
europepmc +1 more source
Improvement of the predictive value of CD4+ lymphocyte count by b2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate [PDF]
Bek, Barbara +6 more
core
The impact of the choice of common data model (CDM) approach on the study results in a real‐world evidence (RWE) study is unknown. We aimed to determine potential differences in the results of an RWE study when data were mapped to two different CDMs, ConcePTION and OMOP. With the same instance of CPRD GOLD, data were mapped to both CDMs. Using the same
Nicholas B. Hunt +8 more
wiley +1 more source
Human Immunodeficiency Virus Test Anxiety of Adult Individuals Undergoing Human Immunodeficiency Virus Testing at an Anonymous Testing Center in Türkiye: A Qualitative Study. [PDF]
Muslu A +3 more
europepmc +1 more source
Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development
When the acquired immunodeficiency syndrome emerged in the 1980s, the United States National Institutes of Health established research networks to conduct clinical trials with the pharmaceutical industry to identify effective antiretroviral therapeutics.
Robin DiFrancesco +17 more
wiley +1 more source
Human immunodeficiency virus: a case of household transmission. [PDF]
AlGhaithi R +3 more
europepmc +1 more source
Pharmacometrics (PMX) in Africa has transitioned from foundational capacity‐building to job creation, scientific leadership, regulatory influence, and health innovation. To accelerate this progress, the 2025 Pharmacometrics Africa Conference (PMXAC‐2025) convened key stakeholders to consolidate the continental PMX community, review progress in local ...
Babatunde Ayodeji Adeagbo +12 more
wiley +1 more source
Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency. [PDF]
Desjardins A +15 more
europepmc +1 more source
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
Bayinqiaoge +2 more
wiley +1 more source

